Newly Diagnosed

Metastatic OM

Resources

OM Registry / BioBank

Education & Events

Eye Believe Survivorship Seminar

Swing for Sight

Looking for a Cure 5k

Steps for Sight

Join A Cure in Sight alongside mental health professionals, social workers, patients, and more for a half-day seminar on Sunday January 25, 2026. This seminar is designed to support those living with ocular melanoma. We’ll explore ways to reframe your diagnosis, build resilience, and focus on a future filled with empowerment and wellness so you can not just survive ocular melanoma, but THRIVE with it.

This event is packed with practical resources, relatable discussions, strategies for navigating your journey, and tools to help you live well with your diagnosis. Come ready to take notes, reflect, and begin reshaping your mindset with guidance from experts and fellow OM community members.

***Sessions will be recorded and available on our Youtube channel following the event. Be sure to subscribe to the channel here:

https://www.youtube.com/@acureinsight4912

Please note, sessions, topics, and speakers subject to change.

A Cure in Sight for Ocular Melanoma

Ocular Melanoma (Uveal Melanoma): Trusted Guidance and Support
Ocular melanoma, also known as uveal melanoma, is a rare but serious eye cancer. At A Cure In Sight (ACIS), we empower patients and families by providing clear, reliable resources to navigate this diagnosis. From understanding treatment options to exploring clinical trials, ACIS is here to support you every step of the way.

Navigating Ocular Melanoma with ACIS

A diagnosis of ocular melanoma can feel overwhelming. That’s why ACIS focuses on creating a strong support community where patients and caregivers can connect, share experiences, and find encouragement. Through partnerships, we bridge gaps in education and ensure access to essential resources.

Driving Research for Ocular Melanoma

Research plays a critical role in improving outcomes for ocular melanoma. ACIS funds innovative projects to accelerate treatment advancements and move closer to a cure. Our commitment ensures that no opportunity for progress is missed.